These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 8497271

  • 1. Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression.
    Musgrove EA, Hamilton JA, Lee CS, Sweeney KJ, Watts CK, Sutherland RL.
    Mol Cell Biol; 1993 Jun; 13(6):3577-87. PubMed ID: 8497271
    [Abstract] [Full Text] [Related]

  • 2. Effects of the progestin antagonist RU 486 on T-47D breast cancer cell cycle kinetics and cell cycle regulatory genes.
    Musgrove EA, Sutherland RL.
    Biochem Biophys Res Commun; 1993 Sep 30; 195(3):1184-90. PubMed ID: 8216247
    [Abstract] [Full Text] [Related]

  • 3. Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation.
    Musgrove EA, Sarcevic B, Sutherland RL.
    J Cell Biochem; 1996 Mar 01; 60(3):363-78. PubMed ID: 8867812
    [Abstract] [Full Text] [Related]

  • 4. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
    Prall OW, Sarcevic B, Musgrove EA, Watts CK, Sutherland RL.
    J Biol Chem; 1997 Apr 18; 272(16):10882-94. PubMed ID: 9099745
    [Abstract] [Full Text] [Related]

  • 5. Antiprogestin inhibition of cell cycle progression in T-47D breast cancer cells is accompanied by induction of the cyclin-dependent kinase inhibitor p21.
    Musgrove EA, Lee CS, Cornish AL, Swarbrick A, Sutherland RL.
    Mol Endocrinol; 1997 Jan 18; 11(1):54-66. PubMed ID: 8994188
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of retinoids and antiestrogens on cell cycle progression and cell cycle regulatory genes in human breast cancer cells.
    Wilcken NR, Sarcevic B, Musgrove EA, Sutherland RL.
    Cell Growth Differ; 1996 Jan 18; 7(1):65-74. PubMed ID: 8788034
    [Abstract] [Full Text] [Related]

  • 7. Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells.
    Watts CK, Sweeney KJ, Warlters A, Musgrove EA, Sutherland RL.
    Breast Cancer Res Treat; 1994 Jan 18; 31(1):95-105. PubMed ID: 7981461
    [Abstract] [Full Text] [Related]

  • 8. Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation.
    Watts CK, Brady A, Sarcevic B, deFazio A, Musgrove EA, Sutherland RL.
    Mol Endocrinol; 1995 Dec 18; 9(12):1804-13. PubMed ID: 8614416
    [Abstract] [Full Text] [Related]

  • 9. Cyclin D1 overexpression induces progestin resistance in T-47D breast cancer cells despite p27(Kip1) association with cyclin E-Cdk2.
    Musgrove EA, Hunter LJ, Lee CS, Swarbrick A, Hui R, Sutherland RL.
    J Biol Chem; 2001 Dec 14; 276(50):47675-83. PubMed ID: 11590147
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.
    Carroll JS, Swarbrick A, Musgrove EA, Sutherland RL.
    Cancer Res; 2002 Jun 01; 62(11):3126-31. PubMed ID: 12036924
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes.
    Musgrove EA, Lee CS, Sutherland RL.
    Mol Cell Biol; 1991 Oct 01; 11(10):5032-43. PubMed ID: 1922031
    [Abstract] [Full Text] [Related]

  • 14. Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells.
    Doisneau-Sixou SF, Sergio CM, Carroll JS, Hui R, Musgrove EA, Sutherland RL.
    Endocr Relat Cancer; 2003 Jun 01; 10(2):179-86. PubMed ID: 12790780
    [Abstract] [Full Text] [Related]

  • 15. A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence.
    Carroll JS, Prall OW, Musgrove EA, Sutherland RL.
    J Biol Chem; 2000 Dec 08; 275(49):38221-9. PubMed ID: 10991938
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL, Buffolino P, Kopman C, Nathanson L.
    Exp Cell Res; 1995 Nov 08; 221(1):92-102. PubMed ID: 7589260
    [Abstract] [Full Text] [Related]

  • 18. Insulin-like growth factor-I induces cyclin-D1 expression in MG63 human osteosarcoma cells in vitro.
    Furlanetto RW, Harwell SE, Frick KK.
    Mol Endocrinol; 1994 Apr 08; 8(4):510-7. PubMed ID: 8052269
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cells.
    Fiddes RJ, Janes PW, Sivertsen SP, Sutherland RL, Musgrove EA, Daly RJ.
    Oncogene; 1998 May 28; 16(21):2803-13. PubMed ID: 9652748
    [Abstract] [Full Text] [Related]

  • 20. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.
    Sweeney KJ, Sarcevic B, Sutherland RL, Musgrove EA.
    Oncogene; 1997 Mar 20; 14(11):1329-40. PubMed ID: 9178893
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.